We have used 14 DNA probes, which detect 19 different restriction enzyme length polymorphisms, t o search for heterozygosity on chromosome 3 in five cell lines isolated from patients with small cell lung carcinoma. The cell lines on karyotype analysis did not show the deletion in chromosome 3 charac
Characterization of the submicroscopic deletion in the small-cell lung carcinoma (SCLC) cell line U2020
β Scribed by Dr. Harry A. Drabkin; Mike J. Mendez; Pamela H. Rabbitts; Terry Varkony; Jonas Bergh; Joseph Schlessinger; Paul Erickson; Robert M. Gemmill
- Book ID
- 102845413
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 673 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
β¦ Synopsis
The small-cell lung carcinoma cell line U2020 contains a submicroscopic, homozygous deletion that removes a chromosomal segment within 3p 13-p 14, including the locus D3S3. W e have sublocalized 49 additional probes to the 3p 13-p 14.2 region and have identified 7 new D N A markers that arise from within the U2020 deletion. The estimated size of the deletion, based on marker density, is approximately 4-5 megabases (Mb). Including D3S3, 7 of the 8 markers have been linked by pulsed-field gel (PFG) electrophoresis over an area of approximately 2 Mb. Including the one unlinked marker, PFG analysis accounts for about 3 Mb of the region. The U2020 deletion appears confined to the 3p 13-p 14.2 region and does not include the candidate tumor suppressor gene, protein-tyrosine phosphatase gamma (PTPG). Genes Chrom Cancer 5:67-74 ( I 992). @ 1992 WiIey-Liss. Inc.
π SIMILAR VOLUMES
## Abstract Homozygous deletions are instrumental in the detection and cloning of tumor suppressor genes. We report the isolation and characterization of 39 new singleβcopy probes saturating a submicroscopic homozygous deletion detected in the DNA of the small cell lung cancer (SCLC) cell line U202
## BACKGROUND. The number of elderly people with small cell lung carcinoma (SCLC) is increasing and currently nearly 25% are older than 70 years. Elderly patients may not tolerate intensive therapy and, therefore, often do not receive such treatment. Additionally, age may be an independent predicto
## Abstract Small cell carcinoma of the lung is extremely sensitive to chemotherapy and radiation therapy. We describe the case of a patient who had a complete response to such treatment but relapsed with meningeal carcinomatosis. We propose that prophylactic therapy to the spinal cord as well as t